A systematic review of the accuracy and utility of early markers of ifosfamide-induced proximal tubulopathy in survivors of childhood cancers

Pediatric Hematology and Oncology

Volumn 25, Issue 2, 2008, Pages 107-113

  Phillips, Robert S ^a   Tyerman, Kay ^a   Al Kassim, Mohammed Imran ^b   Picton, Susan ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b HARROGATE DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Aminoaciduria 2 microglobulinuria; Ifosfamide; Predictive tests; Proximal tubular nephropathy; Systematic review

Indexed keywords

CARBOPLATIN; CISPLATIN; IFOSFAMIDE;

ACCURACY; AMINOACIDURIA; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; HUMAN; KIDNEY TUBULE DISORDER; SYSTEMATIC REVIEW;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FANCONI SYNDROME; FEMALE; HUMANS; IFOSFAMIDE; INFANT; MALE; MEDLINE; NEOPLASMS; SURVIVORS;

EID: 41149162177     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701885276     Document Type: Article

References (9)

1. Lee BS, Lee JH, Kang HG, Hahn H. Ifosfamide nephrotoxicity in pediatric cancer patients. Pediatr Nephrol. 2001;16:796-799.
2. Suarez A, McDowell H, Niaudet P, Comoy E. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report. J Clin Oncol.. 1991;9:2177-2182.
3. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer . 2000; 82:1636-1645.
4. Stroup DF, Berlin JA, Morton SC, et al. for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008-2012.
5. Tokuc G, Yalciner A, Kebudi R, Dogan S. Renal dysfunction secondary to ifosfamide treatment in children. J Exp Clin Cancer Res. 1997;16:227-230.
6. Ho P, Zimmerman K, Wexler L, Blaney S. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer. 1995;76:2557-2564.
7. Caron H, Abeling N, van Gennip A, de Kraker J. Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens. Med Pediatr Oncol. 1994;22:153-154.
8. Rossi R, Pleyer J, Schafers P. Development of ifosfamide induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol. 1999;32:177-182.
9. http://www.cclg.org.uk/public/followup/PracticeStatement/index.html [Accessed July 2007]